With regard to The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study [27], it was found that the administration of low dose colchicine did not contribute to the reduction of hs-CRP which is independent of aspirin and statin in patients with coronary artery disease. The gene discussed is CRP; the disease is coronary artery disorder.